Extended adjuvant endocrine therapy in early breast cancer: a meta-analysis of published randomized trials Ezzeldin M. IbrahimMarwan R. Al-HajeiliAhmed A. Refae Original Paper 15 June 2017 Article: 131
Erratum to: Advances in systemic therapy for metastatic breast cancer: future perspectives S. P. CoronaN. SobhaniD. Generali Erratum 14 June 2017 Article: 130
Neutralization of matrix metalloproteinase-9 potentially enhances oncolytic efficacy of tanapox virus for melanoma therapy Tiantian ZhangYogesh R. SuryawanshiKarim Essani Original Paper 07 June 2017 Article: 129
Aberrant gene promoter methylation of E-cadherin, p16 INK4a , p14 ARF , and MGMT in Epstein–Barr virus-associated oral squamous cell carcinomas Ati BurassakarnChamsai PientongTipaya Ekalaksananan Original Paper 02 June 2017 Article: 128
Downregulation of TRPM7 suppressed migration and invasion by regulating epithelial–mesenchymal transition in prostate cancer cells Liang ChenRui CaoYu Xiao Original Paper 01 June 2017 Article: 127
Expanding the search for significant EGFR mutations in NSCLC outside of the tyrosine kinase domain with next-generation sequencing Matthew K. SteinLindsay MorrisMike G. Martin Original Paper 01 June 2017 Article: 126
Minimally invasive pancreatic cancer surgery: What is the current evidence? Michał PędziwiatrPiotr MałczakAndrzej Budzyński Review Article Open access 01 June 2017 Article: 125
Peribiliary liver metastases MR findings Vincenza GranataRoberta FuscoAntonella Petrillo Original Paper 01 June 2017 Article: 124
Clinical significance of androgen secretion disorders in men with a malignancy Pawel J. WiechnoGrazyna M. PoniatowskaTomasz Demkow Review Article Open access 01 June 2017 Article: 123
Epithelial-to-mesenchymal transition in tumor progression Elena Prieto-GarcíaC. Vanesa Díaz-GarcíaM. Teresa Agulló-Ortuño Review Article 30 May 2017 Article: 122
Paradigm shift of therapeutic management of brain metastases in EGFR-mutant non-small cell lung cancer in the era of targeted therapy Akimasa SekineHiroaki Satoh Review Article 29 May 2017 Article: 121
Why do younger breast cancer patients with blood group O have favorable prognosis? Kadri Altundag Letter to the Editor 23 May 2017 Article: 120
Advances in systemic therapy for metastatic breast cancer: future perspectives S. P. CoronaN. SobhaniD. Generali Review Article 19 May 2017 Article: 119
